S100A2 and lung carcinoma: To avoid the confounding factor from TP53 mutations, we instead used 2 cell lines derived from oral and lung cancer, OC328 and A54929, both of which express wildtype TP53. Although at a lower level, both cell lines also expressed S100A2 mRNA when compared to aHK (Supplementary Fig. S3).